Latest headlines
Regeneron Pharmaceuticals News
The latest Regeneron Pharmaceuticals (REGN) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these REGN headlines next to the live Regeneron Pharmaceuticals Fear and Greed Index.
Latest Regeneron Pharmaceuticals Headlines58
Regeneron Pharmaceuticals, Inc. Notice of September 14, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline
globenewswire.com · Aug 7, 2026
REGN Deadline Alert: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of Securities Class Action Deadline on September 14, 2026
globenewswire.com · Aug 7, 2026
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com · Aug 7, 2026
REGN UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com · Aug 7, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
prnewswire.com · Aug 6, 2026
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit
prnewswire.com · Aug 6, 2026
SueWallSt Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN
prnewswire.com · Aug 6, 2026
Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit – Hagens Berman
globenewswire.com · Aug 5, 2026
Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock
zacks.com · Aug 5, 2026
REGN or INCY: Which Is the Better Value Stock Right Now?
zacks.com · Aug 5, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
feeds.newsfilecorp.com · Aug 5, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com · Aug 5, 2026
REGN Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky
prnewswire.com · Aug 5, 2026
REGN Stock Drop: If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Leading the Class Action Lawsuit
businesswire.com · Aug 5, 2026
REGN EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com · Aug 5, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
globenewswire.com · Aug 4, 2026
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN)
globenewswire.com · Aug 4, 2026
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit
prnewswire.com · Aug 4, 2026
REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt
globenewswire.com · Aug 4, 2026
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com · Aug 4, 2026
Regeneron (REGN) is a Top-Ranked Value Stock: Should You Buy?
zacks.com · Aug 4, 2026
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN
prnewswire.com · Aug 4, 2026
REGN Stock Drop: Regeneron Clinical Trials Lead to 9% Stock Drop and Securities Fraud Class Action for Investors
prnewswire.com · Aug 4, 2026
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com · Aug 3, 2026
REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure
globenewswire.com · Aug 3, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com · Aug 3, 2026
REGN Investor Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
globenewswire.com · Aug 3, 2026
Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron's Eylea® 2 mg
businesswire.com · Aug 3, 2026
REGN Class Action Notice: Regeneron Hit with Securities Fraud Lawsuit over Trial Misrepresentations – Investors Urged to Contact BFA Law by September 14 Deadline
globenewswire.com · Aug 3, 2026
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
gurufocus.com · Aug 3, 2026
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN
gurufocus.com · Aug 3, 2026
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com · Aug 3, 2026
Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN
prnewswire.com · Aug 3, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com · Aug 2, 2026
REGN CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com · Aug 1, 2026
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSS
prnewswire.com · Jul 31, 2026
REGN DEADLINE: The Gross Law Firm Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
globenewswire.com · Jul 31, 2026
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
globenewswire.com · Jul 31, 2026
$REGN Securities: Suffer Losses on Your Regeneron Investment? BFA Law Reminds Investors of the Securities Fraud Lawsuit to Recover Losses
globenewswire.com · Jul 31, 2026
REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure
globenewswire.com · Jul 30, 2026
REGN SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com · Jul 30, 2026
Regeneron Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com · Jul 30, 2026
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 30, 2026
Regeneron Q2 Earnings Beat, Sales Up on Dupixent & Eylea HD Strength
zacks.com · Jul 30, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
newsfilecorp.com · Jul 30, 2026
Regeneron (REGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com · Jul 30, 2026
REGN Deadline Alert: SueWallSt Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026
prnewswire.com · Jul 30, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
prnewswire.com · Jul 30, 2026
Regeneron (REGN) Q2 Earnings and Revenues Top Estimates
zacks.com · Jul 30, 2026
Regeneron beats quarterly estimates on eczema drug strength, shares rise
reuters.com · Jul 30, 2026
Regeneron Reports Second Quarter 2026 Financial and Operating Results
globenewswire.com · Jul 30, 2026
REGN Stockholders Have Rights – If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Recovering Your Losses
globenewswire.com · Jul 29, 2026
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman
gurufocus.com · Jul 29, 2026
REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit - Hagens Berman
prnewswire.com · Jul 29, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com · Jul 29, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com · Jul 29, 2026
REGN UPCOMING DEADLINE: Levi & Korsinsky Alerts Regeneron Pharmaceuticals, Inc. Stockholders of Securities Class Action - Contact the Firm
prnewswire.com · Jul 29, 2026
REGENERNON PHARMACEUTICALS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 14, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
globenewswire.com · Jul 29, 2026
Why Is Regeneron Pharmaceuticals Up or Down Today?
When Regeneron Pharmaceuticals (REGN) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a REGN move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Regeneron Pharmaceuticals is up or down today.
How Regeneron Pharmaceuticals News Affects the Price
News does not move the Regeneron Pharmaceuticals (REGN) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Regeneron Pharmaceuticals Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Regeneron Pharmaceuticals trading volume. That is the chain to watch: headline, sentiment, volume, then the REGN price.
Trade the Regeneron Pharmaceuticals News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Regeneron Pharmaceuticals trading volume spike on a big story, check the Regeneron Pharmaceuticals price history for context, follow the live REGN price, see the Regeneron Pharmaceuticals price prediction, and read the Regeneron Pharmaceuticals Fear and Greed Index for mood.
How do you feel about Regeneron Pharmaceuticals?
1DFrequently asked questions
Why is Regeneron Pharmaceuticals up or down today?
What is the latest Regeneron Pharmaceuticals news?
Where does Regeneron Pharmaceuticals news come from?
How often is Regeneron Pharmaceuticals news updated?
How does Regeneron Pharmaceuticals news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.